TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive NCI Considering Proposal To Form “Drug Discovery Cooperative Groups”; Concept To DCT Board In June February 26, 1982
TCL Archive White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson December 2, 1988
TCL Archive Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models November 20, 1998